SV1996000001A - Nuevas aplicaciones de dimero de lisozima - Google Patents

Nuevas aplicaciones de dimero de lisozima

Info

Publication number
SV1996000001A
SV1996000001A SV1996000001A SV1996000001A SV1996000001A SV 1996000001 A SV1996000001 A SV 1996000001A SV 1996000001 A SV1996000001 A SV 1996000001A SV 1996000001 A SV1996000001 A SV 1996000001A SV 1996000001 A SV1996000001 A SV 1996000001A
Authority
SV
El Salvador
Prior art keywords
entrepreneurs
applications
new
lisozyme
dimer
Prior art date
Application number
SV1996000001A
Other languages
English (en)
Inventor
Witold Kiczka
Original Assignee
Nika Health Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nika Health Products Ltd filed Critical Nika Health Products Ltd
Publication of SV1996000001A publication Critical patent/SV1996000001A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Fish Paste Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

COMPOSICIONES FARMACEUTICAS QUE CONTIENEN UN DEIMERO DE LISOZIMA, PREFERIBLEMENTE DE ALTA PUREZA, ES DECIR CON AL MENOS 10% ENPESO O MENOS DE SUBPRODUCTOS NO DESEADOS, Y NUEVAS APLICACIONES DEL MISMO. TALES APLICACIONES INCLUYEN ADMINISTRACION TOPICA, ORAL Y PARENTERAL DE LAS MENCIONADAS COMPOSICIONES PARA INMUNOESTIMULACION NO ESPECIFICA COMO UNA MEDIDA DE TRATAMIENTO DE PREVENCION Y/O TERAPEUTICO DE ENFERMEDADES DE HUMANOS Y ANIMALES QUE COMPRENDEN CANCER, TRASTORNOS DEL CRECIMIENTO DEL PELO, ENFERMEDADES DE PECES Y ENFRMEDADES DE ABEJAS.LA ESTIMULACION NO ESPECIFICA DEL SISTEMA INMUNE ESTA INDUCIDA MEDIANTE UNA APLICACION UNICA O REPETIDA DE LA COMPOSICION DE DIMERO DE LISOZIMA, PREFERIBLEMENTE A CONCENTRACIONES DE 5 A 500 UG/KG DE PESO CORPORAL .
SV1996000001A 1995-01-13 1996-01-12 Nuevas aplicaciones de dimero de lisozima SV1996000001A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95100446 1995-01-13
EP95110638 1995-07-07

Publications (1)

Publication Number Publication Date
SV1996000001A true SV1996000001A (es) 1997-02-17

Family

ID=26138401

Family Applications (1)

Application Number Title Priority Date Filing Date
SV1996000001A SV1996000001A (es) 1995-01-13 1996-01-12 Nuevas aplicaciones de dimero de lisozima

Country Status (38)

Country Link
EP (2) EP1086703A3 (es)
JP (1) JPH10511974A (es)
KR (1) KR100420377B1 (es)
CN (1) CN1090506C (es)
AP (2) AP628A (es)
AT (1) ATE218367T1 (es)
AU (1) AU709620B2 (es)
BA (1) BA96074A (es)
BG (1) BG62239B1 (es)
BR (1) BR9606973A (es)
CA (1) CA2210091A1 (es)
CZ (1) CZ293353B6 (es)
DE (2) DE804227T1 (es)
DZ (1) DZ1964A1 (es)
EA (1) EA001462B1 (es)
EE (1) EE9700154A (es)
ES (1) ES2109208T1 (es)
FI (1) FI972943A (es)
GB (1) GB2311724B (es)
GE (1) GEP20012571B (es)
GR (1) GR970300047T1 (es)
HK (1) HK1002060A1 (es)
HR (1) HRP960014A2 (es)
HU (1) HU223903B1 (es)
IL (1) IL116737A (es)
MA (1) MA23775A1 (es)
MD (1) MD1633C2 (es)
MY (1) MY132437A (es)
NO (1) NO973203D0 (es)
NZ (1) NZ298432A (es)
OA (1) OA10436A (es)
PL (1) PL185678B1 (es)
SK (1) SK94297A3 (es)
SV (1) SV1996000001A (es)
TN (1) TNSN96004A1 (es)
TR (1) TR199700633T1 (es)
UA (1) UA50728C2 (es)
WO (1) WO1996021463A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6123937A (en) * 1997-03-14 2000-09-26 Nika Health Products, Limited Applications of lysozyme dimer
TR200003146T2 (tr) * 1998-04-27 2001-03-21 Nika Health Products Limited Doğurganlığı geliştirici bileşik ve onun uygulamaları.
AUPP489798A0 (en) * 1998-07-28 1998-08-20 Mediko Pty Ltd Hair growth/maintenance compositions and methods
US7846430B2 (en) * 2007-03-02 2010-12-07 Stefano Ferrari Composition and method for treating bovine papilloma virus in equine
CN103518978B (zh) * 2013-10-22 2016-01-13 上海艾魁英生物科技有限公司 新型溶菌酶制剂及其制备方法
US10653613B2 (en) 2013-12-18 2020-05-19 Dsm Ip Assets B.V. Compositions comprising lysozyme hydrolysate for use in keratin-containing tissue
CN104585546B (zh) * 2015-01-20 2019-02-05 上海海洋大学 一种促生长抗应激罗非鱼饲料及其制备方法
CN105707509B (zh) * 2016-01-25 2018-12-28 浙江艾杰斯生物科技有限公司 一种用于防治草鱼烂腮病的饲料添加剂
WO2020099556A1 (en) 2018-11-14 2020-05-22 Universiteit Antwerpen Oxidized lysozyme
EP4003300A4 (en) * 2019-07-26 2023-06-28 Infinant Health, Inc Nutritive compositions with bioactive proteins
CN111657407A (zh) * 2020-05-14 2020-09-15 上海艾魁英生物科技有限公司 提高断奶仔猪非特异性免疫功能的饲料添加剂、其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5533408A (en) * 1978-08-30 1980-03-08 Eisai Co Ltd Immunity-increasing agent
JPS5543040A (en) * 1978-09-25 1980-03-26 Eisai Co Ltd Immunity raising agent
DE3230999A1 (de) * 1982-08-20 1984-02-23 Philips Kommunikations Industrie AG, 8500 Nürnberg Verfahren zur zugriffssteuerung bei einem nachrichtensystem
EP0181634A3 (en) * 1984-11-14 1987-09-09 Takeda Chemical Industries, Ltd. Synthetic gene for human lysozyme
RU2061496C1 (ru) * 1985-08-02 1996-06-10 Институт общей патологии и экологии человека Средство, стимулирующее эритропоэз
JPH01501939A (ja) * 1987-01-28 1989-07-06 オーソ・フアーマシユーチカル・コーポレーシヨン 免疫抑制ペプチドおよび使用法
US5200182A (en) * 1988-05-26 1993-04-06 Nika Health Products, Ltd. Antiviral or antibacterial composition and method of use
SG47607A1 (en) * 1990-01-08 1998-04-17 Nika Health Products Ltd Method of preparing ribonuclease dimers
CA2073351C (en) * 1990-01-08 2001-10-16 Peter Herrmann Lysozyme dimers and method of preparing them
PL173978B1 (pl) * 1992-07-13 1998-05-29 Nika Health Products Ltd Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej
RU2082413C1 (ru) * 1993-06-30 1997-06-27 Нижегородский государственный медицинский институт Способ лечения язвенной болезни двенадцатиперстной кишки
RU2071339C1 (ru) * 1994-07-25 1997-01-10 Щербакова Элеонора Григорьевна Средство для лечения и профилактики дисбактериоза
RU2123345C1 (ru) * 1997-07-31 1998-12-20 Научно-исследовательский институт детского питания Российской Академии сельскохозяйственных наук Средство для лечения дисбактериоза

Also Published As

Publication number Publication date
UA50728C2 (uk) 2002-11-15
AU709620B2 (en) 1999-09-02
TNSN96004A1 (fr) 2005-03-15
HUP9801689A3 (en) 2000-07-28
NO973203L (no) 1997-07-10
MD970244A (en) 1999-05-31
EP0804227A2 (en) 1997-11-05
ES2109208T1 (es) 1998-01-16
DE804227T1 (de) 1998-04-09
EA199700101A1 (ru) 1997-12-30
CZ293353B6 (cs) 2004-04-14
HUP9801689A2 (hu) 1998-10-28
HU223903B1 (hu) 2005-03-29
GB2311724B (en) 1999-07-21
BG101709A (en) 1998-03-31
EP1086703A3 (en) 2001-05-02
GEP20012571B (en) 2001-11-26
KR100420377B1 (ko) 2004-05-20
NO973203D0 (no) 1997-07-10
MA23775A1 (fr) 1996-10-01
AU4391696A (en) 1996-07-31
GB9714354D0 (en) 1997-09-10
MD1633C2 (ro) 2001-10-31
AP9701024A0 (en) 1997-07-31
WO1996021463A2 (en) 1996-07-18
NZ298432A (en) 2001-03-30
HRP960014A2 (en) 1997-12-31
EE9700154A (et) 1997-12-15
SK94297A3 (en) 1998-01-14
JPH10511974A (ja) 1998-11-17
AP628A (en) 1998-02-27
CN1177303A (zh) 1998-03-25
GR970300047T1 (en) 1997-12-31
EP0804227B1 (en) 2002-06-05
IL116737A0 (en) 1996-05-14
EA001462B1 (ru) 2001-04-23
EP1086703A2 (en) 2001-03-28
ATE218367T1 (de) 2002-06-15
PL321546A1 (en) 1997-12-08
OA10436A (en) 2001-12-07
DE69621589D1 (de) 2002-07-11
FI972943A0 (fi) 1997-07-11
KR19980701337A (ko) 1998-05-15
MD1633B2 (en) 2001-03-31
WO1996021463A3 (en) 1996-09-19
BG62239B1 (bg) 1999-06-30
CN1090506C (zh) 2002-09-11
PL185678B1 (pl) 2003-07-31
AP9600783A0 (en) 1996-04-30
DZ1964A1 (fr) 2002-10-15
CA2210091A1 (en) 1996-07-18
IL116737A (en) 2000-02-17
HK1002060A1 (en) 1998-07-31
GB2311724A (en) 1997-10-08
TR199700633T1 (xx) 1998-01-21
MY132437A (en) 2007-10-31
BA96074A (bs) 1999-08-02
BR9606973A (pt) 1999-01-26
AP871A (en) 2000-09-10
CZ220297A3 (cs) 1998-02-18
FI972943A (fi) 1997-07-11

Similar Documents

Publication Publication Date Title
RU94028670A (ru) Иммунопотенциирующие агенты, способы лечения иммунодефицитных млекопитающих, а также вирусных инфекций и рака у млекопитающих
FR2416012A1 (fr) Derives de l'imidazole et medicament contenant ces substances
MX9301929A (es) Derivados de pirimidina y procedimientos para su preparacion.
ES2093440T3 (es) Derivados en la serie de la vitamina d con modificaciones en la posicion 20, procedimiento para su preparacion, productos intermedios para este procedimiento, preparados farmaceuticos que contienen estos derivados asi como su utilizacion para la preparacion de medicamentos.
FR2714378B1 (fr) Dérivés de l'indol-2-one substitués en 3 par un groupe azoté, leur préparation, les compositions pharmaceutiques en contenant.
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
IL105727A (en) 7-(2-mercapto-acetamido)-octahydro-6-oxopyrido[2,1-a][2]-benzazepine derivatives analogs thereof their preparation and pharmaceutical enkephalinase-inhibiting compositions containing them
EP0564739A3 (es)
LV12766A (lv) Composition of l-dopa esters
BG101118A (en) Therapeutical compounds
SV1996000001A (es) Nuevas aplicaciones de dimero de lisozima
MX9205466A (es) Procedimiento para la preparacion de un medicamento para la administracion oral o topica en el tratamiento de leishmaniasis
IL97796A0 (en) Pharmaceutical compositions containing n-alkylated 1,4-dihydropyridine-dicarboxylic acid esters,certain such compounds and their preparation
KR830002510A (ko) 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물
KR880007080A (ko) 제약학적 생성물
CA2107485A1 (fr) Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ES2130246T3 (es) Nucleosidos terapeuticos de la serie 2',3'-didesoxi-3'-fluoro-purina.
MY119473A (en) Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them
ES8707111A1 (es) Procedimiento para obtencion de un preparado farmaceutico para tratamiento terapeutico de enfermedades reumaticas.
CA2078869A1 (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
FR2700166B1 (fr) Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
IL106588A0 (en) Liponucleotides of seconucleosides,processes for the preparation thereof and pharmaceutical compositions with antiviral action containing them
MY111746A (en) Therapeutic nucleosides.
MX9705246A (es) Nuevas aplicaciones de dimero de lisozina.
YU896A (sh) Farmaceutski sastav sa sadržajem lizozomskog dimera